Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis.  Donaldson SR, Radley A, Dillon JF.  Harm Reduct J. 2025 Jan 16;22(1):10. doi: 10.1186/s12954…

Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study.  Manley HN, Riback LR, Nyakowa M, Akiyama MJ, Cherutich P, Lizcano J, Kurth A, Muller A.  PLOS Glob Public Health. 2025 Jan 16;…

Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics?  Stopka TJ, Nance RM, Mixson LS, Spencer H, Tsui JI, Leahy JM, Pho MT, DeJace J, Feinberg J, Young AM, Yang WT, Baltes A, Ro…

Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir.  Yi S, Truong D, Conway B.  J Virus Erad. 2024 Dec 3;10(4):100569. doi: 10.1016/j.jve.2024.100569. PMID: 3980712…

Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection.  Steffen G, Krings A, Guttmann S, Lübke N…

Neues Konzept leistet Vorschub für die Impfstoffentwicklung gegen Hepatitis C Lübeck – Ein vielversprechendes Konzept weckt die Hoffnung auf die Entwicklung eines wirksamen Impfstoffs gegen das Hepatitis-C-Virus (HCV). Neuartig konstruierte Immunog…